Annual report [Section 13 and 15(d), not S-K Item 405]

Balance Sheets

v3.25.4
Balance Sheets - USD ($)
Dec. 31, 2025
Dec. 31, 2024
Current assets    
Cash and cash equivalents $ 6,811,000 $ 3,951,000
Restricted cash 94,000 93,000
Deferred offering costs 634,000
Prepaid expenses and other current assets 567,000 188,000
Total Current Assets 8,106,000 4,232,000
TOTAL ASSETS 8,106,000 4,232,000
Current liabilities    
Accounts payable 748,000 3,853,000
Accrued expenses 1,560,000 1,797,000
Warrant liability 11,000 252,000
Total Current Liabilities 2,319,000 5,902,000
Stockholders’ Equity (Deficit)    
Common stock, par value $0.001, 250,000,000 shares authorized, 25,534,173 and 2,234,328 shares issued and outstanding as of December 31, 2025 and 2024, respectively 26,000 2,000
Additional paid in capital 729,661,000 693,554,000
Accumulated deficit (723,901,000) (695,227,000)
Total Stockholders’ Equity (Deficit) 5,787,000 (1,670,000)
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) 8,106,000 4,232,000
Series C Preferred Stock [Member]    
Stockholders’ Equity (Deficit)    
Preferred stock value 1,000 1,000
Series L Preferred Stock [Member]    
Stockholders’ Equity (Deficit)    
Preferred stock value